Which treatment is indicated to manage symptoms of Alzheimer's disease?

The management of symptoms associated with Alzheimer's disease often involves medications that primarily aim to enhance cholinergic neurotransmission. Galantamine, Donepezil, and Rivastigmine are all acetylcholinesterase inhibitors, which work by preventing the breakdown of acetylcholine, a neurotransmitter that is typically deficient in individuals with Alzheimer's.

Each of these medications contributes to managing cognitive symptoms, including memory loss and confusion, by increasing the levels of acetylcholine in the brain. They are indicated for the treatment of mild to moderate Alzheimer's disease and can help improve or stabilize cognitive function in some patients.

Using all three medications reflects an understanding of the broad spectrum of cholinergic support available for Alzheimer's symptoms. Therefore, considering that each of these treatments serves a similar purpose in the management of Alzheimer's, the choice indicating all of them as options is appropriate.